Abbott Laboratories
ABT
$88.66
$0.891.01%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.72% | -80.76% | -0.12% | 36.64% | 8.16% |
| Total Depreciation and Amortization | 6.22% | -1.86% | -1.25% | -3.48% | -6.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.69% | -69.98% | 2.56% | 0.71% | -4.93% |
| Change in Net Operating Assets | 7.45% | 107.33% | 64.54% | -126.04% | 27.20% |
| Cash from Operations | -7.20% | 15.59% | 3.03% | 4.44% | 38.24% |
| Capital Expenditure | 17.56% | 4.31% | 10.79% | 5.82% | -21.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,007.14% | -39.73% | 347.37% | -163.29% | 151.85% |
| Cash from Investing | -4,224.26% | -5.43% | 23.06% | -28.48% | -10.59% |
| Total Debt Issued | 1,989,000.00% | 100.00% | -100.00% | -99.10% | -- |
| Total Debt Repaid | -36.55% | 88.27% | -1,273.81% | 72.13% | -716.54% |
| Issuance of Common Stock | -59.58% | -80.00% | -25.00% | 169.23% | 114.18% |
| Repurchase of Common Stock | 35.71% | 4.13% | 59.39% | -100.00% | -23.89% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -7.02% | -7.52% | -7.40% | -7.08% | -7.21% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 942.48% | 24.93% | -11.68% | -38.69% | -74.74% |
| Foreign Exchange rate Adjustments | -195.83% | 107.23% | -127.78% | 492.31% | 166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -58.58% | 1,643.10% | -1.93% | -40.40% | -77.12% |